Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?
Guardado en:
Autores principales: | Lei Zhao, Wu Zhong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/867f50019729452a9979da087a11be05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
por: Jean-Sélim Driouich, et al.
Publicado: (2021) -
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
por: Ashleigh Shannon, et al.
Publicado: (2020) -
Combined treatment of molnupiravir and favipiravir against SARS-CoV-2 infection: One + zero equals two?
por: Philippine Eloy, et al.
Publicado: (2021) -
2019nCoVR—A comprehensive genomic resource for SARS-CoV-2 variant surveillance
por: Guoqing Lu, et al.
Publicado: (2021) -
Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2
por: Hector Huerga Encabo, et al.
Publicado: (2021)